SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-031624
Filing Date
2022-11-14
Accepted
2022-11-14 08:01:11
Documents
63
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 996590
2 ex31-1.htm EX-31.1 17334
3 ex31-2.htm EX-31.2 17287
4 ex32-1.htm EX-32.1 9441
  Complete submission text file 0001493152-22-031624.txt   5492968

Data Files

Seq Description Document Type Size
5 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ghsi-20220930.xsd EX-101.SCH 45272
6 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ghsi-20220930_cal.xml EX-101.CAL 55251
7 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ghsi-20220930_def.xml EX-101.DEF 183239
8 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ghsi-20220930_lab.xml EX-101.LAB 401319
9 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ghsi-20220930_pre.xml EX-101.PRE 292031
57 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 843712
Mailing Address 2925 RICHMOND AVENUE SUITE 1200 HOUSTON TX 77098
Business Address 2925 RICHMOND AVENUE SUITE 1200 HOUSTON TX 77098 (800) 873-5141
Guardion Health Sciences, Inc. (Filer) CIK: 0001642375 (see all company filings)

IRS No.: 474428421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38861 | Film No.: 221380424
SIC: 2834 Pharmaceutical Preparations